Advertisement
Screener

SIGHT SCIENCES, INC. (SGHT) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

2.1 / 5 stars · 16/38 Roast Me

SIGHT SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

SIGHT SCIENCES, INC. (SGHT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-03-04

  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-06-30 was 0.00%.
  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2025-09-300.00%
10-Q · filed 2025-11-06
2024-12-310.00%
10-K · filed 2026-03-04
2024-06-300.00%
10-Q · filed 2025-08-07
0.00%
10-Q · filed 2025-08-07
2024-03-310.00%
10-Q · filed 2025-05-08
2023-12-310.00%
10-K · filed 2025-03-07
2023-09-300.00%
10-Q · filed 2023-11-07
2023-06-300.00%
10-Q · filed 2023-08-07
2023-03-310.00%
10-Q · filed 2023-05-08
2022-12-310.00%
10-K · filed 2024-03-13
2022-09-300.00%
10-Q · filed 2022-11-10
2021-12-310.00%
10-K · filed 2023-03-16
2021-06-300.00%
10-Q · filed 2021-11-10
2020-12-310.00%
10-K · filed 2022-03-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
NeuroPace Inc (NPCE)United States$0.480B-28.52
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
CARLSMED, INC. (CARL)United States$0.405B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Orthofix Medical Inc. (OFIX)$0.373B
SS Innovations International, Inc. (SSII)$0.589B-64.06
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39